The relationship between stent expansion conditions and clinical outcomes is not
completely understood. This prospective cohort study included patients who were
successfully implanted with second-generation drug-eluting stent in 2012 and
received follow-up angiography in 9-12 months. Stent over-expansion was defined
as
Cite this article
56
Downloads
1
Citations
162
Views
Announcements
Open Access
Original Research
Over-expansion of second-generation drug-eluting stents, risk of restenosis, and relation to major adverse cardiac events
Show Less
1
Department of Cardiology, Fujian Heart Medical Center, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Institute of Geriatrics, Fujian, 350001, P. R. China
*Correspondence: lianglongchenfjxh@126.com (Lianglong Chen)
Rev. Cardiovasc. Med. 2020, 21(3), 481–487;
https://doi.org/10.31083/j.rcm.2020.03.27
Submitted: 8 March 2020 | Revised: 8 June 2020 | Accepted: 15 June 2020 | Published: 30 September 2020
Copyright: © 2020 Yi et al. Published by IMR Press.
This is an open access article under the CC BY-NC 4.0 license (https://creativecommons.org/licenses/by-nc/4.0/).
Abstract
Keywords
Stent over-expansion
second-generation drug-eluting stent
in-stent restenosis
late lumen loss
major cardiac adverse event
Figures
Fig. 1.